Paradigm Biocapital Advisors LP, 10% Owner at Olema Pharmaceuticals, Inc. (OLMA), sold 4,800,000 shares at $14.92 ($71.6M) on 2024-08-01, disclosed to the SEC on 2024-08-05.
Open-market sale of $71.6M OLMA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.92 | 529,501 | $7.9M | 11.0% |
| 2 | $14.92 | 529,501 | $7.9M | 11.0% |
| 3 | $14.92 | 1,870,499 | $27.9M | 39.0% |
| 4 | $14.92 | 1,870,499 | $27.9M | 39.0% |
| Total | $14.92 avg | 4,800,000 | $71.6M | 100% |